Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
And with its FDA Category 2 classification, sourcing pharmaceutical-grade AOD-9604 has become increasingly difficult
What Is AOD-9604
Initially described as a pro-atherogenic molecule due to its proliferative role in VSMC, it was further demonstrated that the effect of IGF-I on VSMC was to compensate for local apoptosis, and that, overall, IGF-I is not pro-atherogenic in native arteries but anti-atherogenic[320], mainly through enhanced nitric oxide production[308]
Fukuda, A
Although they adjusted the data for other influential factors like age, sex, ethnicity, other health conditions, and medication use, they cannot exclude other elements that may have impacted the results
US$ 20.18
US$ 23.16
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 20.77
US$ 21.17
